As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...

California Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state's pharmaceutical venture. Beginning Jan. 1, consumers can purchase a five-pack of pens for a ...

AstraZeneca has signed a $555 million deal with San Francisco biotech Algen Biotechnologies that will tap the latter company’s artificial intelligence platform to boost discovery of new targets in ...